Peter A. Noseworthy, MD, MBA, is a Professor of Medicine, Chair of the Division of Heart Rhythm Services (Cardiac Electrophysiology), and Medical Director of Business Development.

In his role as Medical Director, Dr. Noseworthy oversees proactive business partnerships and strategic collaborations, mergers and acquisitions, equity investing and the commercialization of Mayo Clinic technologies for the benefit of patients worldwide while generating revenue to support clinical practice, research, and education at Mayo Clinic.

Dr. Noseworthy joined the Mayo Clinic faculty in 2013 after completing his internal medicine, cardiology, chief residency and electrophysiology training at Massachusetts General Hospital in Boston, MA. He completed his Master of Business Administration from MIT in 2023.

He has closely partnered with Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery to maintain a federally funded research program that leverages cutting-edge research methods as well as emerging data and technologies. This work has led to a series of high-impact publications that address questions important to patients, clinicians and health systems.

He also helps to lead a multidisciplinary team develop novel ECG software-based analysis tools, many of which have resulted in the filing of intellectual property disclosures and several patents.